GBA1 and Gaucher disease: The human lysosomal enzyme acid-β-glucosidase (also known as glucocerebrosidase or GCase) has recently become an increasingly interesting biological target to address not only the most common form of lysosomal storage disorders (LSDs), Gaucher disease (GD), but also much more common neurological pathologies, such as Parkinson’s disease (PD).